Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas

Ding, SN; Mao, X; Cao, Y; Wang, N; Xu, H; Zhou, JF

Xu, H; Zhou, JF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, 1095 Jie Fang Ave, Wuhan 430030, Hubei, Peoples R China.; Xu, H; Zhou, JF (corresponding author), Immunotherapy Res Ctr Hematol Dis Hubei Prov, Wuhan, Hubei, Peoples R China.

TARGETED ONCOLOGY, 2020; 15 (3): 365

Abstract

Background Although chimeric antigen receptor (CAR) T-cell therapy targeting antigens expressed in refractory and relapsed non-Hodgkin B-cell lymphoma......

Full Text Link